IOVAIovance Biotherapeutics, Inc.

$8.09

Who owns IOVA

280 institutions reported holding IOVA for 2026Q1, together 64% of the company, more than the 260 a quarter earlier.

280

Institutions reporting a position · as of 2026Q1 · up from 260 the quarter before

Shares held by institutions
268.9M

Shares held by institutions · 64% of the company · long US equity positions only, as reported on Form 13F

Reported value
$943M

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
29%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
36
New positions
55
Positions exited
41
Added to
113
Reduced
55
Top 10 holdersof the company
40%
Institutional ownership by quarter, 2017Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1280268.9M$943M
2025Q4260261.6M$715M
2025Q3250212.9M$462M
2025Q2253220.2M$379M
2025Q1294239.6M$798M
2024Q4298241.2M$1.78B
2024Q3282235.2M$2.21B
2024Q2292232.5M$1.86B
2024Q1270217.2M$3.22B
2023Q4232207.3M$1.69B
2023Q3223213.0M$969M
2023Q2215203.9M$1.44B
2023Q1225205.2M$1.25B
2022Q4217173.1M$1.11B
2022Q3241154.2M$1.48B
2022Q2233159.3M$1.75B
Largest reported holders, 2026Q1
HolderShares% of companyValue
BlackRock Inc.31.1M7.4%$109M
VANGUARD GROUP INC30.9M7.4%$109M
MHR FUND MANAGEMENT LLC29.0M6.9%$102M
STATE STREET CORP17.4M4.2%$61M
TWO SIGMA INVESTMENTS, LP13.7M3.3%$48M
MILLENNIUM MANAGEMENT LLC9.4M2.2%$33M
GOLDMAN SACHS GROUP INC8.8M2.1%$31M
GEODE CAPITAL MANAGEMENT LLC8.6M2.0%$30M
Invenomic Capital Management LP8.5M2.0%$30M
BANK OF AMERICA CORP /DE/8.5M2.0%$30M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…